Scinovex
review

Fast-dissolving oral film of anti-migraine drug: A review

National Journal of Pharmaceutical Sciences · 2021 · Vol. 1(2) · pp. 40–48

Abstract

Patient suffering from Migraine with nausea, vomiting, and sensitivity to light/sound be given an oral film of the drug Anti -Migraine Drug to relieve and ease their pain. An intense headache that is prone to recurrence, especially in women. A week is the most common, but it can also happen once every few years or less often. A few hours to three days, depending on the severity of the injury. In general, morning headaches affect only one side of the head, typically the forehead side. Headaches, which can be extremely painful, are very common. These conditions are the most common causes of headaches, accounting for 95 percent or more of all complaints. Based on the transdermal patch technology, mouth dissolving films are a new drug delivery system for oral delivery of drugs. When a patient's tongue or any other mucosal tissue is wetted by saliva, a thin oral strip is placed on the patient's tongue or mucosal tissue, which quickly hydrates and sticks to the application site. Upon swallowing it, it rapidly disintegrates and dissolves, releasing the medication for oro-mucosal absorption. Unlike other existing, the rapid films can be produced at a cost comparable to that of conventional tablets using fast-dissolving films to deliver anti-migraine drugs for migraine treatment is a novel and promising approach.

Botulinum Toxin and Related Neurological DisordersAdvanced Drug Delivery SystemsNeurological Disorders and TreatmentsMigraineHeadachesMedicineNauseaVomitingTongueForeheadAnesthesiaTransdermal patchTransdermal
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
54%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Fast-dissolving oral film of anti-migraine drug: A review · Scinovex